Sponsor Pipeline

Jiangsu BioJeTay Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT06922045
Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients		 Enrollment closed, study ongoing
2026-08-13 NCT06929299
A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in…		 date change Primary completion pushed: 2026-06 -> 2026-09
2026-08-13 NCT06929299
A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in…		 date change Completion pushed: 2026-06 -> 2026-09
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06922045 Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients Hemophilia Active, Not Recruiting
Phase 1/2
NCT06929299 A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in… Primary Immune Thrombocytopenia (ITP) Recruiting
Disease Areas
Hemophilia (1)
Get alerts when Jiangsu BioJeTay Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free